accountKing Pharmaceuticals' (KG) fourth quarter earnings of $0.23 were a penny shy of the Zacks Consensus Estimate....
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to King Pharmaceuticals (KG)
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account